Recent Acquisition of Code Bleu

FINANCIAL OVERVIEW FOR THE YEAR ENDED SEPTEMBER 30, 2020 FINANCIAL OVERVIEW Year ended September Year ended September RESULTS 30, 2020 30, 2019 CAPITALIZATION As at September 30 2020 Revenues $20,739,973 $11,617,783 Held by insiders 66.1% 30,053,335 Direct costs $15,027,783 $9,062,828 Public float 19.6% Gross margin $5,712,190 $2,554,955 Common shares (9-30-2020) Administrative expenses $3,740,122 $1,819,921 Code Bleu acquisition 14.3% Operating income $1,972,068 $735,034 Common shares (12-31-2020) 8,900,418 38,953,753 6,521,739 45,475,492 Financial expenses $199,844 $221,335 BASIC / DILUTED Non-recurring items $1,331,059 $0 Basic 45,475,492 Stock based compensation $0 $0 Warrants (price/outstanding) $0.32 3,368,321 Current income taxes $413,244 $89,594 Options (price/outstanding) $0.23 1,450,849 Net income $27,921 1 EBITDA $2,120,630 $424,105 $868,407 Fully Diluted 51,997,231 Net Debt (9-30-2020) $11,401,411 Adjusted EBITDA excludes non-cash and non-recurring items such as listing fees and acquisition costs. PREMIER HEALTH OF AMERICA CONFIDENTIAL - NOT FOR DISTRIBUTION 16

View entire presentation